iZafe Group AB (publ.) - Exercise of Warrants Under LTIP 2023

December 16, 2025 11:15 AM

iZafe Group (STO:IZAFE-B) (the "Company") announces that all participants in the Company's long-term incentive program LTIP 2023 have exercised their Series A warrants for subscription of shares in the Company.LTIP 2023 was approved by the extraordinary general meeting held on 21 December 2023 and comprised a total of 7,907,877 warrants, divided into three series (A-C). Through the exercise of Series A warrants, employees and key personnel...

Read more

Medical Care Technologies (OTC Pink:MDCE) Deploys AI to Identify Historic Memorabilia Acquisitions Strengthening Long-Term Financial Stability

December 16, 2025 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) is thrilled to announce the powerful collaboration between its subsidiaries, Real Game Used (RGU) and Infinite Auctions. Utilizing RGU's patent-pending AI technology, Infinite Auctions has successfully identified and acquired rare, photo-matched memorabiliasignificantly more valuable than their purchase price. AI-Driven Photo-Match Discoveries and Synergy in ActionThis collaboration highlights the...

Read more

One Year After Go-Live, NOVO Hospital Confirms the Long-Term Value of Digital Pathology with Tribun Health

December 16, 2025 8:00 AM

One year after deploying CaloPix®, the digital pathology platform developed by Tribun Health, NOVO Hospital (Val-d'Oise, France) reports clear, measurable improvements in efficiency, collaboration, and diagnostic workflows.In a healthcare environment marked by rising case volumes, staff shortages, and growing demands for accuracy, this digital transformation was not just technical - it was strategic.Clear, measurable, and rapid outcomesThe full...

Read more

How to Choose the Best Plastic Surgeon in Tampa, FL: Gruber Plastic Surgery Releases Patient Safety Checklist

December 16, 2025 7:00 AM

When people search "best plastic surgeon in Tampa," they aren't looking for a slogan; they want a reliable way to choose the right surgeon for their goals and their safety. Gruber Plastic Surgery, led by board‑certified plastic surgeon Meegan Gruber, MD, PhD, has published a concise, patient‑friendly checklist designed to help Tampa Bay patients evaluate cosmetic surgery providers using clear, practical criteria. The new guide, "What to Know...

Read more

CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics

December 16, 2025 6:00 AM

(OTCQB:CTTH) CTT Pharmaceutical Holdings, Inc. is pleased to announce that a peer-reviewed scientific paper has been published in the journal of Drug Delivery and Therapeutics, authored by our scientist Dr. Katharine Cole and Dr. Pankaj Modi, the founder of CTT Pharma. The article provides the first comprehensive scientific review describing how micellar nanotechnology, when combined with an oral dissolvable strip delivery system, can...

Read more

Genflow Completes Dosing Phase of Canine Gene Therapy Trial

December 16, 2025 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), a biotechnology company focused on extending healthspan through advanced gene therapies, today announced that all dogs enrolled in its ongoing clinical trial have successfully received the full administration of the Company's investigational SIRT6-based gene therapy.Importantly, no adverse events were reported during the dosing phase of the study. No serious,...

Read more

President Trump Cleaning Up Biden's Marijuana Mess - MMJ Preparing to Move FDA Huntington's Cannabis Trials Forward

December 16, 2025 1:45 AM

As reports circulate that President Trump will issue an executive order directing federal agencies to finalize the long-stalled move of marijuana to Schedule III, MMJ International Holdings today framed the action not as a new policy, but as the necessary move to correct the regulatory vacuum created by Biden's administration. The failure to complete the rescheduling process, initiated by the Biden White House in October 2022, has resulted in...

Read more

Healthcare Payer IT in 2026: Digital Prior Authorization, Enforceable Transparency, and Outcomes-Driven Platforms Spark a New Acquisition Race

December 15, 2025 8:30 PM

The healthcare payer information technology (IT) sector continues to evolve rapidly, and 2026 is positioned to be a pivotal execution year for regulatory compliance programs and modernization roadmaps. Insights derived from Black Book Research survey findings of 1,158 payer IT and administrative users (Q2-Q4 2025) indicate that payer organizations are prioritizing investments that reduce administrative friction, strengthen cybersecurity posture,...

Read more

New National Alliance Launches to Address Health Workforce Shortages in Underserved Communities

December 15, 2025 5:50 PM

Leading national organizations have come together to form the Alliance to Strengthen America's Health Workforce for the Underserved, a coalition committed to addressing critical workforce shortages and advancing policies that support healthcare professionals serving underserved communities. The coalition's Executive Committee includes Advocates for Community Health (ACH), the Association of Clinicians for the Underserved (ACU), the National...

Read more

Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million

December 15, 2025 4:00 PM

Champions Oncology, Inc. (Nasdaq:CSBR), a leading translational oncology research organization, today announced its financial results for its second quarter of fiscal 2026, ended October 31, 2025.Second Quarter and Recent Highlights:Total revenue increased 11% to $15 millionOncology services profit of $7.8 million; oncology services margin of 52%Net income of $237,000Adjusted EBITDA of $843,000First Half 2026 Highlights:Total revenue increased...

Read more

Prosta Peak Reviews (URGENT REPORT) Why This 20-Ingredient Prostate Formula Is Setting the New Standard for Men Over 40 in 2025

December 15, 2025 2:00 PM

Prostate health issues don't arrive with warning signs, they creep in quietly. One extra bathroom trip at night turns into three. A weaker urinary stream becomes daily frustration. By the time most men start searching for Prosta Peak reviews, the problem is no longer hypothetical, it's affecting sleep, energy, confidence, and daily routines. That urgency is exactly why prostate supplements are one of the fastest-growing men's health categories...

Read more

Kerassentials Reviews (URGENT REPORT) Why This 8-in-1 Antifungal Oil Is Trending And What Buyers Must Know

December 15, 2025 11:40 AM

Toenail fungus and persistent nail discoloration are far more common than most people admit, and in 2025, searches for Kerassentials reviews have surged as frustrated buyers look for alternatives to harsh creams, prescriptions, and temporary fixes. The Original Kerassentials positions itself as an 8-in-1, plant-based antifungal oil, marketed as a daily topical solution designed to support clearer nails and healthier skin over time. But as...

Read more

Synadentix Reviews (URGENT REPORT) New Oral Microbiome Research Reveals What This Enzyme Supplement Really Does

December 15, 2025 9:30 AM

Synadentix has exploded across oral-health searches in 2025, appearing in dentist forums, microbiome research discussions, and consumer complaint boards simultaneously. What makes these Synadentix Reviews different is that the supplement positions itself as more than an "oral probiotic." Instead, Synadentix claims to use a rare combination of hydroxyapatite minerals, oral-specific enzymes, immune proteins, and microbiome-balancing agents that...

Read more

Medical Care Technologies, Inc. (OTC Pink:MDCE) Completes First AI Consumer App Targeting Deployment Across 100+ Countries and 30 Languages

December 15, 2025 9:11 AM

Medical Care Technologies, Inc. (OTC Pink:MDCE) today announced the completion of its first AI-based consumer application, marking a major milestone in the Company's strategy to build scalable, revenue-generating artificial intelligence platforms while continuing development of advanced medical AI solutions. The newly completed application is designed for broad consumer adoption and global reach. The app is expected to be deployed in over 100...

Read more

Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults

December 15, 2025 9:00 AM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced the commercial availability of EXXUA in the United States. EXXUA is the first and only 5HT1a agonist approved by the United States Food and Drug Administration for the treatment of major depressive disorder ("MDD"),...

Read more

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

December 15, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that Jaguar family company Napo Pharmaceuticals' (Napo's) independent investigator at a leading SBS-IF treatment institution submitted an abstract describing preliminary findings from a clinical trial evaluating a novel oral liquid formulation of crofelemer in adult SBS-IF patients. This abstract is for consideration for presentation at the May 2-5, 2026 Digestive Disease Week®...

Read more

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)

December 15, 2025 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending marketing authorization of mNEXSPIKE® (mRNA-1283), a new COVID vaccine, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals aged 12 years and older. Following the CHMP's positive opinion, the European Commission will make a marketing...

Read more

Amphastar Announces FDA Approval for Teriparatide Injection

December 15, 2025 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New Drug Application ("ANDA") for teriparatide injection, USP 560 mcg/2.24mL (250 mcg/mL) single-patient-use prefilled pen. The FDA determined that Amphastar's teriparatide is bioequivalent and therapeutically equivalent to Eli Lilly's FORTEO®."We are proud to announce FDA approval of Amphastar's...

Read more

Multi Sciences Elevates Research Access with Global Bioz Badges Roll-out

December 15, 2025 4:00 AM

Bioz, Inc., the leading AI-powered engine for scientific product insights, proudly announces the deployment of 1,000 Bioz Badges on Multi Sciences' English and Chinese product webpages. International researchers can now readily access publication-backed validation of Multi Sciences' comprehensive reagent portfolio, including ELISA kits, recombinant proteins, cellular assay kits and related buffers and reagents.The enriched webpages dynamically...

Read more

Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics

December 15, 2025 1:20 AM

MindMaze Therapeutics Holding SA (SIX:MMTX) (MindMaze Therapeutics or the Company) announced today the completion of its business combination with NeuroX Group SA (NeuroX), a commercial-stage company delivering evidence-based, precision digital treatments for neurological diseases. The newly combined entity now operates under the name MindMaze Therapeutics Holding SA. The closing follows the signing of a definitive business combination agreement...

Read more